394 related articles for article (PubMed ID: 16939410)
1. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
[TBL] [Abstract][Full Text] [Related]
3. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
Fujiwara T; Saito S; Osanai T; Kameda K; Abe N; Higuma T; Yokoyama J; Hanada H; Fukui K; Fukuda I; Okumura K
Eur J Pharmacol; 2008 Oct; 594(1-3):146-51. PubMed ID: 18703045
[TBL] [Abstract][Full Text] [Related]
5. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
[TBL] [Abstract][Full Text] [Related]
6. The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
Furenes EB; Arnesen H; Solheim S; Grøgaard HK; Hoffmann P; Seljeflot I
Thromb Res; 2009 Nov; 124(5):560-4. PubMed ID: 19410278
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
[TBL] [Abstract][Full Text] [Related]
8. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
10. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
11. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
Nie R; Xie S; Du B; Liu X; Deng B; Wang J
Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction.
Tziakas DN; Chalikias GK; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI; Kaski JC
Am J Cardiol; 2005 Jul; 96(1):31-4. PubMed ID: 15979428
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
[TBL] [Abstract][Full Text] [Related]
16. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
Matsunaga T; Abe N; Kameda K; Hagii J; Fujita N; Onodera H; Kamata T; Ishizaka H; Hanada H; Osanai T; Okumura K
Int J Cardiol; 2005 Nov; 105(2):203-8. PubMed ID: 16243114
[TBL] [Abstract][Full Text] [Related]
17. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.
Suezawa C; Kusachi S; Murakami T; Toeda K; Hirohata S; Nakamura K; Yamamoto K; Koten K; Miyoshi T; Shiratori Y
J Lab Clin Med; 2005 Jan; 145(1):33-40. PubMed ID: 15668659
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
[TBL] [Abstract][Full Text] [Related]
20. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
